Stay updated on VAX-24 Safety in Older Adults Clinical Trial
Sign up to get notified when there's something new on the VAX-24 Safety in Older Adults Clinical Trial page.

Latest updates to the VAX-24 Safety in Older Adults Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study objectives and inclusion/exclusion criteria for a clinical trial on the VAX-24 pneumococcal vaccine, while adding new terminology and a revision number.SummaryDifference22%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check81 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check96 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check103 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to VAX-24 Safety in Older Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VAX-24 Safety in Older Adults Clinical Trial page.